Literature DB >> 26985677

Human alveolar epithelial cells expressing tight junctions to model the air-blood barrier.

Anna Kuehn1, Stephanie Kletting1, Cristiane de Souza Carvalho-Wodarz1, Urska Repnik2, Gareth Griffiths2, Ulrike Fischer3, Eckart Meese3, Hanno Huwer4, Dagmar Wirth5,6, Tobias May7, Nicole Schneider-Daum1, Claus-Michael Lehr1,8.   

Abstract

This paper describes a new human alveolar epithelial cell line (hAELVi - human Alveolar Epithelial Lentivirus immortalized) with type I-like characteristics and functional tight junctions, suitable to model the air-blood barrier of the peripheral lung. Primary human alveolar epithelial cells were immortalized by a novel regimen, grown as monolayers on permeable filter supports and characterized morphologically, biochemically and biophysically. hAELVi cells maintain the capacity to form tight intercellular junctions, with high trans-epithelial electrical resistance (> 1000 Ω*cm²). The cells could be kept in culture over several days, up to passage 75, under liquid-liquid as well as air-liquid conditions. Ultrastructural analysis and real time PCR revealed type I-like cell properties, such as the presence of caveolae, expression of caveolin-1, and absence of surfactant protein C. Accounting for the barrier properties, inter-digitations sealed with tight junctions and desmosomes were also observed. Low permeability of the hydrophilic marker sodium fluorescein confirmed the suitability of hAELVi cells for in vitro transport studies across the alveolar epithelium. These results suggest that hAELVi cells reflect the essential features of the air-blood barrier, as needed for an alternative to animal testing to study absorption and toxicity of inhaled drugs, chemicals and nanomaterials.

Entities:  

Keywords:  ATI cells; Lentivirus immortalization; inhalation toxicology; pulmonary drug delivery

Mesh:

Year:  2016        PMID: 26985677     DOI: 10.14573/altex.1511131

Source DB:  PubMed          Journal:  ALTEX        ISSN: 1868-596X            Impact factor:   6.043


  30 in total

1.  Biomimetics of the pulmonary environment in vitro: A microfluidics perspective.

Authors:  Janna Tenenbaum-Katan; Arbel Artzy-Schnirman; Rami Fishler; Netanel Korin; Josué Sznitman
Journal:  Biomicrofluidics       Date:  2018-05-29       Impact factor: 2.800

Review 2.  The impact of nanomaterial characteristics on inhalation toxicity.

Authors:  Frank S Bierkandt; Lars Leibrock; Sandra Wagener; Peter Laux; Andreas Luch
Journal:  Toxicol Res (Camb)       Date:  2018-02-01       Impact factor: 3.524

Review 3.  Bioengineering the Blood-gas Barrier.

Authors:  Katherine L Leiby; Micha Sam Brickman Raredon; Laura E Niklason
Journal:  Compr Physiol       Date:  2020-03-12       Impact factor: 9.090

4.  In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells.

Authors:  Raïko Blondonnet; Bertille Paquette; Damien Richard; Rémi Bourg; Géraldine Laplace; Romain Segurel; Henria Pouvelle; Corinne Belville; Loic Blanchon; Thomas Godet; Jean-Michel Constantin; Jean-Etienne Bazin; Vincent Sapin; Matthieu Jabaudon
Journal:  J Vis Exp       Date:  2018-10-23       Impact factor: 1.355

Review 5.  New insights into the mechanisms of pulmonary edema in acute lung injury.

Authors:  Raquel Herrero; Gema Sanchez; Jose Angel Lorente
Journal:  Ann Transl Med       Date:  2018-01

Review 6.  Innovative preclinical models for pulmonary drug delivery research.

Authors:  Stephan Ehrmann; Otmar Schmid; Chantal Darquenne; Barbara Rothen-Rutishauser; Josue Sznitman; Lin Yang; Hana Barosova; Laurent Vecellio; Jolyon Mitchell; Nathalie Heuze-Vourc'h
Journal:  Expert Opin Drug Deliv       Date:  2020-02-23       Impact factor: 6.648

7.  Characterization of Novel Human Immortalized Thyroid Follicular Epithelial Cell Lines.

Authors:  Kristen Hopperstad; Theresa Truschel; Tom Wahlicht; Wendy Stewart; Andrew Eicher; Tobias May; Chad Deisenroth
Journal:  Appl In Vitro Toxicol       Date:  2021-06-16

8.  Disease Models: Lung Models for Testing Drugs Against Inflammation and Infection.

Authors:  Patrick Carius; Justus C Horstmann; Cristiane de Souza Carvalho-Wodarz; Claus-Michael Lehr
Journal:  Handb Exp Pharmacol       Date:  2021

Review 9.  Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics.

Authors:  Arbel Artzy-Schnirman; Sivan Arber Raviv; Ofri Doppelt Flikshtain; Jeny Shklover; Netanel Korin; Adi Gross; Boaz Mizrahi; Avi Schroeder; Josué Sznitman
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 15.470

Review 10.  In Vitro Models for Studying Respiratory Host-Pathogen Interactions.

Authors:  Sarah L Barron; Janire Saez; Róisín M Owens
Journal:  Adv Biol (Weinh)       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.